Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Przewalsk sage root blood activating medicine and preparation method thereof

A technology of blood-activating medicine and Zidan, which is applied in the direction of medical formula, drug combination, cardiovascular system diseases, etc., can solve the problem of drug failure and achieve the effects of lowering blood pressure, dilating coronary arteries, and improving coronary microcirculation

Inactive Publication Date: 2011-11-23
YUNNAN CHUXIONG TIANLI PHARMA
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Although at present, medicines for the treatment of cardiovascular and cerebrovascular diseases with Panax notoginseng and Dansan as the main ingredients are already on the market, but there is no medicine that combines the two organically to achieve the best therapeutic effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] This embodiment provides a Zidan blood-activating medicine and a preparation method thereof. The raw material formula of the medicine is as follows:

[0033] Panax notoginseng saponins 25g Zidansan 312.5g glycerin 2g

[0034] Hydroxypropyl methylcellulose 3.65g Titanium dioxide 2.32g

[0035] This formula can be used to make 1000 Zidan blood-activating medicine tablets. This product is a film-coated tablet, which appears dark brown after removing the coating; has a slight smell, bitter taste, and sweet aftertaste.

[0036] The medicine is prepared according to the following steps:

[0037] (1) Take purple salvia miltiorrhiza and crush it into coarse powder, add ethanol to reflux and extract after 1.5 hours, and filter to obtain the filtrate for the first time;

[0038] (2) After the filter residue is extracted with dilute ethanol under reflux for 1 hour, filter to obtain the second filtrate;

[0039] (3) merging the first filtrate and the second filtrate, and reclaim...

Embodiment 2

[0051] The difference between this example and Example 1 is that the content of Panax notoginseng saponins and Zidansan in the drug is doubled, and the specific raw material ratios are as follows:

[0052] Panax notoginseng saponins 50g Zidansan 625g glycerin 2g

[0053] Hydroxypropyl methylcellulose 3.65g Titanium dioxide 2.32g

[0054] Taking the tablet prepared by the invention according to the corresponding course of treatment can effectively treat cardiovascular and cerebrovascular diseases caused by qi stagnation and blood stasis.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a przewalsk sage root blood activating medicine and a preparation method thereof. The medicine comprises auxiliary materials and main materials, wherein the auxiliary materials include glycerol, hydroxypropyl methyl cellulose and titanium white; and the main materials include panax notoginseng saponins and przewalsk sage root in a weight ratio of 25 to 312.5. The medicine is prepared inform of tablets by following steps: extracting of the components, mixing, drying and the like. In the invention, panax notoginseng saponins and the przewalsk sage root are combined and glycerol, hydroxypropyl methyl cellulose and titanium white are added, so the przewalsk sage root blood activating medicine can reinforce and improve coronary microcirculation, expand arteria coronaria, increase blood flow in coronary artery, improve the myocardial ischemia and myocardial contractility, regulate rhythm of the heart, reduce rhythm of the heart and blood pressure. The medicine has an obvious treatment effect on cardiovascular and cerebrovascular diseases caused by qi depression to blood stasis, such as coronary disease and cerebral arteriosclerosis and has powerful effects of activating blood, eliminating stasis, regulating qi and relieving pain.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, and in particular relates to a Zidan activating blood medicine and a preparation method thereof. Background technique [0002] Coronary heart disease, coronary heart disease (coronary artery heart disease, CHD) referred to as coronary heart disease, is the most common heart disease, refers to myocardial dysfunction and (or) organic disease caused by coronary artery stenosis and insufficient blood supply. Therefore, it is also called ischemic cardiomyopathy (IHD). CHD is the result of various coronary artery diseases, but coronary atherosclerosis accounts for the vast majority (95%-99%) of coronary heart disease. Therefore, it is customary to regard coronary heart disease as a synonym for coronary atherosclerotic heart disease. [0003] Coronary heart disease symptoms manifest as a crushing pain in the center of the chest cavity, which can spread to the neck, jaw, arms, back and stom...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/537A61K47/38A61K47/02A61P9/10
Inventor 厉君
Owner YUNNAN CHUXIONG TIANLI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products